Article Details
Retrieved on: 2022-08-27 13:29:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Renaissance Technologies LLC owned about 2.19% of Bellerophon Therapeutics worth $258,000 at the end of the most recent reporting period. 12.93% of ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here